News for Dicerna Pharmaceuticals, Inc. (DRNA)

With over 80 key companies active in the RNA therapies space, the market is projected to grow due to advancements in mRNA, siRNA, and antisense...

The increase in emerging industries and the increasing investment in developing advanced technologies are opportunities for liver fibrosis market growth....

Rising awareness of benefits of RNA-based therapeutics and vaccines among healthcare providers and regulatory bodies propelling their production, says...

The primary hyperoxaluria market is anticipated to witness an upsurge in growth in the coming years due to factors such as the increase in the patient pool...

Visiongain has published a new report entitled Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033: Forecasts by Therapeutic Application...

/PRNewswire/ -- Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) has approved RivflozaTM (nedosiran) injection 80 mg, 128 mg, or...

Companies covered in this report are Bontac Bioengineering, Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., F. Hoffmann-La Roche Ltd, HiMedia...

/PRNewswire/ -- The "RNAi Technology Market, By Application, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022-2028" report has been added to...

Conference Call Today at 11:00 a.m. ET LAWRENCEVILLE, N.J., Nov. 14, 2022 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage...

CEO of Curis brings extensive biopharmaceutical financial experience to the Board LAWRENCEVILLE, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Imunon, Inc....

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON OCTOBER 27, 2022 Notice is hereby given that an Annual General Meeting of Shareholders of Quoin... | September 21, 2022

NEW YORK, Dec. 7, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

NEW YORK, Dec. 2, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

GuruFocus Article or News written by insider and the topic is about:

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au...

March 4, 2021 (Investorideas.com Newswire) This latest undertaking of Dicerna Pharmaceuticals and the near-term catalysts of some of its other programs are desc...

Hagens Berman urges XL Fleet Corp. (NYSE: XL) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.